health benefits of glp 1 besides weight loss The expanding GLP-1 medicines: Cell Reports Medicine Understanding GLP-1 | River Oaks

Diabetes 2023;72(Supplement 1):51OR

Over the past several years, incretin-based peptide research has expanded significantly due to promising findings in metabolic signaling studies

When you inject early, you increase the concentration of drug molecules competing for those receptors

At present, the studies of EX on non-diabetic obesity mainly include 152 cases of simple obesity (weight loss of 5.1 kg) (54), 60 cases of polycystic ovary syndrome (weight loss of 3.2-6.0 kg) (55), and 10 cases of metabolic syndrome (weight loss of 3.7 kg) (56), among which the most common adverse reaction is still vomiting

Much like statins have become a drug you take long-term to manage your cholesterol, a GLP-1 pill might become something you take for years to manage your weight

LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept